Hourglass Capital LLC Reduces Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Hourglass Capital LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the third quarter, Holdings Channel.com reports. The institutional investor owned 21,617 shares of the company’s stock after selling 1,090 shares during the quarter. HCA Healthcare makes up approximately 2.4% of Hourglass Capital LLC’s portfolio, making the stock its 6th biggest position. Hourglass Capital LLC’s holdings in HCA Healthcare were worth $8,786,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Plato Investment Management Ltd boosted its position in HCA Healthcare by 51.6% during the third quarter. Plato Investment Management Ltd now owns 4,770 shares of the company’s stock valued at $1,937,000 after purchasing an additional 1,624 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its position in HCA Healthcare by 23.2% during the third quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 2,923 shares of the company’s stock valued at $1,188,000 after purchasing an additional 550 shares in the last quarter. GSA Capital Partners LLP bought a new stake in HCA Healthcare during the third quarter valued at about $567,000. Waverton Investment Management Ltd boosted its position in HCA Healthcare by 12.7% during the third quarter. Waverton Investment Management Ltd now owns 159,382 shares of the company’s stock valued at $64,767,000 after purchasing an additional 17,968 shares in the last quarter. Finally, Nations Financial Group Inc. IA ADV acquired a new stake in HCA Healthcare in the third quarter worth about $325,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. KeyCorp reduced their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Finally, Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Stock Down 0.3 %

HCA Healthcare stock opened at $349.32 on Thursday. The stock has a market capitalization of $88.48 billion, a PE ratio of 15.69, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68. HCA Healthcare, Inc. has a 12 month low of $233.23 and a 12 month high of $417.14. The business has a 50 day simple moving average of $387.95 and a 200-day simple moving average of $357.16. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.